Invesco Pharmaceuticals ETF
PJP
94 hedge funds and large institutions have $75.9M invested in Invesco Pharmaceuticals ETF in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 6 closing their positions.
267% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 6
24% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 21
16% more funds holding
Funds holding: 81 → 94 (+13)
9% more capital invested
Capital invested by funds: $69.3M → $75.9M (+$6.56M)
0.18% more ownership
Funds ownership: 22.92% → 23.1% (+0.18%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$3.29M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$3.23M |
| 3 |
Morgan Stanley
New York
|
+$1.4M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.18M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$730K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$8.29M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.41M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$955K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$435K |
| 5 |
Goldman Sachs
New York
|
-$321K |
PJP Hedge Fund Activity: Q4 2022 in Review
94 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q4 2022, worth a combined $75.9M — up 9.5% from $69.3M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new PJP positions and 6 closed out — a net gain of 16 holders — while 26 added to existing stakes and 21 trimmed.
The largest buyer was Bank of America, adding an estimated $3.29M. The largest seller was Mirae Asset Global Investments, exiting entirely with an estimated $8.29M sold.
- 94 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q4 2022, up from 81 in Q3 2022.
- Funds reported $75.9M of Invesco Pharmaceuticals ETF stock for Q4 2022, up 9.5% quarter-over-quarter.
- 22 funds opened new Invesco Pharmaceuticals ETF positions in Q4 2022 and 6 closed out, a net change of +16 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q4 2022 was Bank of America, an estimated $3.29M added.
- The largest Invesco Pharmaceuticals ETF seller in Q4 2022 was Mirae Asset Global Investments, an estimated $8.29M sold.
Based on aggregated 13F filings for Q4 2022.